These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30608150)

  • 1. Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT
    Singh KD; Unal H; Desnoyer R; Karnik SS
    J Chem Inf Model; 2019 Jan; 59(1):373-385. PubMed ID: 30608150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans and Cis Conformations of the Antihypertensive Drug Valsartan Respectively Lock the Inactive and Active-like States of Angiotensin II Type 1 Receptor: A Molecular Dynamics Study.
    Wang L; Yan F
    J Chem Inf Model; 2018 Oct; 58(10):2123-2130. PubMed ID: 30212210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor.
    Takezako T; Unal H; Karnik SS; Node K
    Mol Pharmacol; 2015 Sep; 88(3):488-501. PubMed ID: 26121982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II cyclic analogs as tools to investigate AT
    St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
    Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 receptor.
    Nivedha AK; Lee S; Vaidehi N
    J Mol Graph Model; 2023 Jan; 118():108365. PubMed ID: 36335829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
    Takezako T; Unal H; Karnik SS; Node K
    Pharmacol Res; 2017 Sep; 123():40-50. PubMed ID: 28648738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting.
    Lymperopoulos A; Borges JI; Stoicovy RA
    Biochem Pharmacol; 2023 Dec; 218():115904. PubMed ID: 37922976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward Understanding the Impact of Dimerization Interfaces in Angiotensin II Type 1 Receptor.
    Erol I; Cosut B; Durdagi S
    J Chem Inf Model; 2019 Oct; 59(10):4314-4327. PubMed ID: 31429557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free cell signaling pathway deconvolution of angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIIIIV responses.
    Lavenus S; Simard É; Besserer-Offroy É; Froehlich U; Leduc R; Grandbois M
    Pharmacol Res; 2018 Oct; 136():108-120. PubMed ID: 29959993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody.
    Wingler LM; McMahon C; Staus DP; Lefkowitz RJ; Kruse AC
    Cell; 2019 Jan; 176(3):479-490.e12. PubMed ID: 30639100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into AT1 receptor activation through AngII binding studies.
    Matsoukas MT; Potamitis C; Plotas P; Androutsou ME; Agelis G; Matsoukas J; Zoumpoulakis P
    J Chem Inf Model; 2013 Nov; 53(11):2798-811. PubMed ID: 24053563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long range effect of mutations on specific conformational changes in the extracellular loop 2 of angiotensin II type 1 receptor.
    Unal H; Jagannathan R; Bhatnagar A; Tirupula K; Desnoyer R; Karnik SS
    J Biol Chem; 2013 Jan; 288(1):540-51. PubMed ID: 23139413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT
    Bernhem K; Krishnan K; Bondar A; Brismar H; Aperia A; Scott L
    BMC Cardiovasc Disord; 2017 May; 17(1):126. PubMed ID: 28514967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor.
    Ali A; Johnstone EKM; Baby B; See HB; Song A; Rosengren KJ; Pfleger KDG; Ayoub MA; Vijayan R
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
    Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
    Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased agonism/antagonism at the AngII-AT1 receptor: Implications for adrenal aldosterone production and cardiovascular therapy.
    Maning J; Negussie S; Clark MA; Lymperopoulos A
    Pharmacol Res; 2017 Nov; 125(Pt A):14-20. PubMed ID: 28511989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalent angiotensin II suppresses oxidative stress-induced hyper-responsiveness of angiotensin II receptor type I.
    Sungkaworn T; Jiarpinitnun C; Chaiyakunvat P; Chatsudthipong V
    Eur J Med Chem; 2013 May; 63():629-34. PubMed ID: 23567951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.
    Wingler LM; Skiba MA; McMahon C; Staus DP; Kleinhenz ALW; Suomivuori CM; Latorraca NR; Dror RO; Lefkowitz RJ; Kruse AC
    Science; 2020 Feb; 367(6480):888-892. PubMed ID: 32079768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activation of thrombin and angiotensin II receptors revealed by bioluminescence resonance energy transfer.
    Al Zamel I; Palakkott A; Ayoub MA
    FEBS Lett; 2021 Oct; 595(20):2628-2637. PubMed ID: 34455594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.